Employees prefer the kitchen table to the boardroom. Photo by Maskot/Getty

For some, working from home is starting to look like the new normal. But whether your office is gearing up for reopening or you're looking at taking calls from your couch for the foreseeable future, one thing is for sure: Texans love that WFH life.

Finance website RealBusinessSavings.com recently surveyed 3,500 American employees to evaluate their attitudes about offices in the current circumstances, and the results showed an overwhelming preference for our makeshift home desks.

The average American employee would take a $316 pay cut per month in order to continue working from home after lockdown, with Texans specifically willing to give up $278 each month to avoid going back to their place of work.

Nationally, 57 percent of employees say they will request to continue working from home to avoid contracting coronavirus in the workplace. One in 10 are happy to be far away from office politics, and two in three say they have been more productive working from home.

When it comes to reasons people prefer to continue working from home, 30 percent of employees say saving money on transportation is the best thing, followed by no daily commute (28 percent). An additional 22 percent say the best part is saving money on lunch and afterwork drinks, while 8 percent said their favorite part is not having to wear business attire (hooray for yoga pants!).

Broken down across the country, it appears Californians are most keen on keeping their WFH routines after lockdown, as the average employee there would forfeit $495 of their salary in order to continue to do so. Comparatively, Hawaii employees are ready to go back to the office, with the average respondent there forfeiting only $71 of their salary each month in order to continue working from home.

And if we ever do return en masse to the boardroom, it seems the days of high-fives and handshakes with your coworkers are over. Results say that 75 percent of employees do not think handshakes will ever return to the work environment, and in their place should be the elbow tap (65 percent), a simple nod (28 percent), the balance-testing foot tap (5 percent), and the formal bow (a mere 2 percent).

Perhaps most telling is this result: One in three workers say that since WFH began, they have felt their bosses have been friendlier and with a more relaxed attitude toward employees. Long live the Zoom meetings.

------

This article originally ran on CultureMap.

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Biosciences startup becomes Texas' first decacorn after latest funding

A Dallas-based biosciences startup whose backers include millionaire investors from Austin and Dallas has reached decacorn status — a valuation of at least $10 billion — after hauling in a series C funding round of $200 million, the company announced this month. Colossal Biosciences is reportedly the first Texas startup to rise to the decacorn level.

Colossal, which specializes in genetic engineering technology designed to bring back or protect various species, received the $200 million from TWG Global, an investment conglomerate led by billionaire investors Mark Walter and Thomas Tull. Walter is part owner of Major League Baseball’s Los Angeles Dodgers, and Tull is part owner of the NFL’s Pittsburgh Steelers.

Among the projects Colossal is tackling is the resurrection of three extinct animals — the dodo bird, Tasmanian tiger and woolly mammoth — through the use of DNA and genomics.

The latest round of funding values Colossal at $10.2 billion. Since launching in 2021, the startup has raised $435 million in venture capital.

In addition to Walter and Tull, Colossal’s investors include prominent video game developer Richard Garriott of Austin and private equity veteran Victor Vescov of Dallas. The two millionaires are known for their exploits as undersea explorers and tourist astronauts.

Aside from Colossal’s ties to Dallas and Austin, the startup has a Houston connection.

The company teamed up with Baylor College of Medicine researcher Paul Ling to develop a vaccine for elephant endotheliotropic herpesvirus (EEHV), the deadliest disease among young elephants. In partnership with the Houston Zoo, Ling’s lab at the Baylor College of Medicine has set up a research program that focuses on diagnosing and treating EEHV, and on coming up with a vaccine to protect elephants against the disease. Ling and the BCMe are members of the North American EEHV Advisory Group.

Colossal operates research labs Dallas, Boston and Melbourne, Australia.

“Colossal is the leading company working at the intersection of AI, computational biology, and genetic engineering for both de-extinction and species preservation,” Walter, CEO of TWG Globa, said in a news release. “Colossal has assembled a world-class team that has already driven, in a short period of time, significant technology innovations and impact in advancing conservation, which is a core value of TWG Global.”

Well-known genetics researcher George Church, co-founder of Colossal, calls the startup “a revolutionary genetics company making science fiction into science fact.”

“We are creating the technology to build de-extinction science and scale conservation biology,” he added, “particularly for endangered and at-risk species.”

Houston investment firm names tech exec as new partner

new hire

Houston tech executive Robert Kester has joined Houston-based Veriten, an energy-focused research, investment and strategy firm, as technology and innovation partner.

Kester most recently served as chief technology officer for emissions solutions at Honeywell Process Solutions, where he worked for five years. Honeywell International acquired Houston-based oil and gas technology company Rebellion Photonics, where Kester was co-founder and CEO, in 2019.

Honeywell Process Solutions shares offices in Houston with the global headquarters of Honeywell Performance Materials and Technologies. Honeywell, a Fortune 100 conglomerate, employs more than 850 people in Houston.

“We are thrilled to welcome Robert to the Veriten team,” founder and CEO Maynard Holt said in a statement, “and are confident that his technical expertise and skills will make a big contribution to Veriten’s partner and investor community. He will [oversee] every aspect of what we do, with the use case for AI in energy high on the 2025 priority list.”

Kester earned a doctoral degree in bioengineering from Rice University, a master’s degree in optical sciences from the University of Arizona and a bachelor’s degree in laser optical engineering technology from the Oregon Institute of Technology. He holds 25 patents and has more than 25 patents pending.

Veriten celebrated its third anniversary on January 10, the day that the hiring of Kester was announced. The startup launched with seven employees.

“With the addition of Dr. Kester, we are a 26-person team and are as enthusiastic as ever about improving the energy dialogue and researching the future paths for energy,” Holt added.

Kester spoke on the Houston Innovators Podcast in 2021. Listen here

.